GeoVax Labs, Inc. (GOVX)
NASDAQ: GOVX · Real-Time Price · USD
1.860
-0.010 (-0.53%)
At close: Mar 12, 2026, 4:00 PM EDT
1.890
+0.030 (1.61%)
After-hours: Mar 12, 2026, 6:08 PM EDT
GeoVax Labs Market Cap
GeoVax Labs has a market cap or net worth of $4.88 million as of March 12, 2026. Its market cap has decreased by -64.79% in one year.
Market Cap
4.88M
Enterprise Value
-125.42K
1-Year Change
-64.79%
Ranking
Category
Stock Price
$1.86
Market Cap Chart
Since September 11, 2019, GeoVax Labs's market cap has increased from $239.88K to $4.88M, an increase of 1,935.84%. That is a compound annual growth rate of 58.97%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 11, 2026 | 4.91M | -33.15% |
| Dec 31, 2025 | 7.34M | -68.49% |
| Dec 31, 2024 | 23.31M | 141.85% |
| Dec 29, 2023 | 9.64M | -41.93% |
| Dec 30, 2022 | 16.60M | -28.16% |
| Dec 31, 2021 | 23.10M | 92.03% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Sep 11, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Aprea Therapeutics | 5.35M |
| Silexion Therapeutics | 5.21M |
| Can-Fite BioPharma | 5.17M |
| MetaVia | 5.17M |
| VivoSim Labs | 4.85M |
| Lunai Bioworks | 4.65M |
| Bio Green Med Solution | 4.64M |
| Revelation Biosciences | 4.58M |